Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Lippo Karawaci Tbk. (LPKR) vs Tempo Scan Pacific Tbk. (TSPC)

Lippo Karawaci Tbk.Trading
Tempo Scan Pacific Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Lippo Karawaci Tbk. dan Tempo Scan Pacific Tbk.: Lippo Karawaci Tbk. diperdagangkan di Rp63 (kapitalisasi pasar 4,54 T, volume 24 jam 159,02 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.790 (kapitalisasi pasar 12,58 T, volume 24 jam 809,6 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 2,8× kapitalisasi pasar Lippo Karawaci Tbk., dan Lippo Karawaci Tbk. lebih aktif diperdagangkan (159,02 jt vs 809,6 rb). Mana yang lebih baik tergantung tujuan investasimu.

LPKRTSPC
Kapitalisasi Pasar
4,54 T12,58 T
Volume
159,02 jt809,6 rb
Lot
1,59 jt8,1 rb
Perputaran
10,08 M2,26 M
Harga Rata-rata
63,412.786,16
Nilai Transaksi
10,08 M2,26 M
Harga Ekuilibrium Indikatif
632.790
Volume Ekuilibrium Indikatif
75,83 rb1,63 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LPKR
Lihat detail
TSPC
Lihat detail

Tentang Lippo Karawaci Tbk.

PT Lippo Karawaci Tbk was established under the name of PT Tunggal Reksakencana on October, 1990. The Company's scope of activities includes real estate, urban development and infrastructure, industrial estate development, general facilities and infrastructure development, services and investments, both direct and indirect, either through its subsidiaries or in joint venture with other parties.

Selengkapnya di halaman LPKR

Tentang Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Selengkapnya di halaman TSPC